Jazz Pharmaceuticals plc
A specialty biopharmaceutical company focused on improving patients’ lives.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Jazz Pharmaceuticals' stock with a target price of $180.47, indicating strong growth potential.
Financial Health
Jazz Pharmaceuticals is achieving strong profits and cash flow, indicating a solid financial position.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring JAZZ
Beyond The Patent Cliff: Pharma's New Growth Engines
AbbVie raised its profit outlook, proving it can thrive after its blockbuster Humira faced competition. This creates an investment opportunity in resilient pharmaceutical companies that are successfully launching new drugs to replace older ones.
Published: August 1, 2025
Explore BasketThe Atlantic Shift: Pharma's US Listing Trend
AstraZeneca's potential move to US markets signals a growing trend among international pharmaceutical companies seeking higher valuations. This collection features global biopharma giants that could benefit from similar strategies or favorable US market dynamics.
Published: July 2, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Pipeline and R&D
Jazz’s clinical pipeline and label-expansion efforts can drive future growth, though clinical setbacks and regulatory hurdles remain possible.
Product Concentration
A handful of products contribute a large share of revenue; successful diversification could reduce risk, while patent loss or competition could weigh on sales.
Strategic Growth Moves
Management pursues acquisitions and in‑licencing to expand indications and markets, a potentially positive route that also carries integration and execution risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
